Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases.

MLA

Cheng, Pin-Nan, et al. “Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan Position Statement for the Management of Metabolic Dysfunction- Associated Fatty Liver Disease and Cardiovascular Diseases.” Clinical and Molecular Hepatology, vol. 30, no. 1, Jan. 2024, pp. 16–36. EBSCOhost, https://doi.org/10.3350/cmh.2023.0315.

APA

Cheng, P.-N., Chen, W.-J., Hou, C. J.-Y., Lin, C.-L., Chang, M.-L., Wang, C.-C., Chang, W.-T., Wang, C.-Y., Lin, C.-Y., Hung, C.-L., Peng, C.-Y., Yu, M.-L., Chao, T.-H., Huang, J.-F., Huang, Y.-H., Chen, C.-Y., Chiang, C.-E., Lin, H.-C., Li, Y.-H., … Liu, C.-J. (2024). Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan position statement for the management of metabolic dysfunction- associated fatty liver disease and cardiovascular diseases. Clinical and Molecular Hepatology, 30(1), 16–36. https://doi.org/10.3350/cmh.2023.0315

Chicago

Cheng, Pin-Nan, Wen-Jone Chen, Charles Jia-Yin Hou, Chih-Lin Lin, Ming-Ling Chang, Chia-Chi Wang, Wei-Ting Chang, et al. 2024. “Taiwan Association for the Study of the Liver-Taiwan Society of Cardiology Taiwan Position Statement for the Management of Metabolic Dysfunction- Associated Fatty Liver Disease and Cardiovascular Diseases.” Clinical and Molecular Hepatology 30 (1): 16–36. doi:10.3350/cmh.2023.0315.